WebDisclosure WebDisclosure
Basculer en Français
10834 Companies
235218 Keywords
164157 Articles
125987 Press releases
Headlines Articles Press releases Supira Medical, Inc. Remove
  1. Home
  2. Companies
  3. Supira Medical, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/08/2026 at 14:10, 4 months 6 days ago

    Supira Medical Gains FDA Nod for SUPPORT II Trial and Welcomes New Board Member

    FDA Approval Board Appointment SUPPORT II Trial Cardiogenic Shock PVAD Innovation
  • BRIEF

    published on 04/08/2026 at 14:10, 4 months 6 days ago

    Supira Medical obtient l'approbation de la FDA pour son essai SUPPORT II et accueille un nouveau membre au conseil d'administration

    Nomination Au Conseil D'administration Approbation De La FDA Essai SUPPORT II Choc Cardiogénique Innovation PVAD
  • PRESS RELEASE

    published on 04/08/2026 at 14:05, 4 months 6 days ago

    Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors

    Supira Medical announces FDA approval for SUPPORT II Pivotal Trial, advances in Cardiogenic Shock, and appointment of D. Keith Grossman to Board of Directors
    FDA Approval Cardiogenic Shock Supira Medical Support II Pivotal Trial D. Keith Grossman
    Logo of Supira Medical, Inc.
Accesswire
  • Published on 08/14/2026 at 13:30, 1 hour 34 minutes ago

    Digi Power X Reports Second Quarter 2026 Financial Results and Provides Operational Update and 2027 Outlook

  • Published on 08/14/2026 at 13:15, 1 hour 49 minutes ago

    Mako Mining Reports Q2 2026 Financial Results, Including Adjusted EBITDA(1) of US$31.7 Million and EPS of US$0.16/Share

  • Published on 08/14/2026 at 13:10, 1 hour 54 minutes ago

    SouthGobi Announces Second Quarter 2026 Unaudited Financial and Operating Results

  • Published on 08/14/2026 at 09:01, 6 hours 3 minutes ago

    Apex Announces Filing of Final Base Shelf Prospectus

  • Published on 08/14/2026 at 08:00, 7 hours 4 minutes ago

    Touchstone Exploration Announces Second Quarter 2026 Results and Operational Update

View all ACCESSWIRE
EQS Group
  • Published on 08/14/2026 at 14:58, 6 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

  • Published on 08/14/2026 at 14:58, 6 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

  • Published on 08/14/2026 at 14:57, 7 minutes ago

    Hypoport Initiates Share Buyback Programme

  • Published on 08/14/2026 at 14:57, 7 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

  • Published on 08/14/2026 at 14:35, 29 minutes ago

    Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock

View all EQS
Les Echos
  • Published on 08/13/2026 at 18:00, 21 hours 4 minutes ago

    Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€

  • Published on 08/11/2026 at 17:45, 2 days 21 hours ago

    DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026

  • Published on 08/11/2026 at 17:40, 2 days 21 hours ago

    Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions

  • Published on 08/10/2026 at 18:00, 3 days 21 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 18:00, 3 days 21 hours ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy